Zhangzhou Pientzehuang Pharmaceutical | 600436 - Umsatzerlöse

Aktienkurs
139.25
Täglich Wechseln
-1.06 -0.76%
Monatlich
-8.69%
Jährlich
-32.01%
Q2 Prognose
138.99




Der Umsatz Veränderung Datum
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Jiangsu Hengrui CNY 8.14B 300M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Moderna USD 678M 342M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Sh Fosun Pharma CNY 9.81B 2.35B 2026-03
Tectonic Therapeutic USD 0 0 2024-12
Viatris USD 3.7B 60M 2025-12
Wuxi Apptec CNY 12.6B 160M 2026-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09